RxDoctor Payments Data

Stephanie Miller, MD

Family Medicine · Cape Gerardeau, MONPI 1144413568

Payments from drug & device makers

$797in general payments, 2019–2025

Across 34 payments — averaging $23.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$149
  • GSK$134
  • Novo Nordisk$77
  • Philips North America LLC$76
  • Novartis$47
  • Viatris Specialty LLC$43
  • plus $272 from 11 others

What the payments were for

  • Food & beverage$797100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$797 in reported general payments places this provider in the 60th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$3,228
Medicare patients
21
Services billed
38

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban54$57,261
OzempicSemaglutide28$29,187
EliquisApixaban30$25,584
TrulicityDulaglutide21$22,940
TradjentaLinagliptin32$19,327
JardianceEmpagliflozin24$18,456
MounjaroTirzepatide11$16,205
JanuviaSitagliptin Phosphate18$15,533
ArexvyRsvpref3 Antigen/As01e/Pf41$11,471
LinzessLinaclotide13$10,836
Combivent RespimatIpratropium/Albuterol Sulfate14$6,897
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr11$5,403
Dexlansoprazole DrDexlansoprazole22$4,914
EntrestoSacubitril/Valsartan15$4,902
Gabapentin325$4,880

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$24$57,26154 claims
Boehringer IngelheimTradjenta, Jardiance, Combivent Respimat$19$44,67970 claims
Lilly USA, LLCTrulicity, Mounjaro$39$39,14532 claims
Novo NordiskOzempic$77$29,18728 claims
GSKArexvy, Anoro Ellipta, Arnuity Ellipta, Shingrix$134$24,11187 claims
MerckJanuvia$29$15,53318 claims
NovartisEntresto$47$4,90215 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Cape Gerardeau

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →